Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Inhibrx, Inc.”

28 pharma patents match "Inhibrx, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 28
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 28 pharmaceutical patents matching "Inhibrx, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

28 results for “Inhibrx, Inc.” · 30,257 patents in full index Clear search

  1. US 12012459

    OX40-binding polypeptides and uses thereof

    Inhibrx, Inc. · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  2. US 11976126

    Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

    Inhibrx, Inc. · Granted May 7, 2024 · Expires May 2, 2044

    granted
  3. US 11965017

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  4. US 11919963

    CD123-binding polypeptides and uses thereof

    Inhibrx, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  5. US 11866507

    Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same

    Inhibrx, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  6. US 11827691

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  7. US 11566078

    PDL1-binding proteins

    Inhibrx, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  8. US 11560428

    CD33-binding polypeptides and uses thereof

    Inhibrx, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  9. US 11434297

    CD123-binding polypeptides and uses thereof

    Inhibrx, Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  10. US 11117973

    Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

    Inhibrx, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  11. US 11117972

    Multivalent and multispecific OX40-binding fusion proteins

    Inhibrx, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  12. US 11046752

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  13. US 10844129

    Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

    Inhibrx, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  14. US 10745466

    Type III secretion system targeting molecules

    Inhibrx, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  15. US 10730929

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  16. US 10723785

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  17. US 10526397

    Non-immunogenic single domain antibodies

    Inhibrx, Inc. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  18. US 10501551

    Multivalent and multispecific 41BB-binding fusion proteins

    Inhibrx, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted
  19. US 10400029

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  20. US 10344078

    Type III secretion system targeting molecules

    Inhibrx, Inc. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  21. US 10308720

    Multivalent and multispecific DR5-binding fusion proteins

    Inhibrx, Inc. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  22. US 10093742

    Multispecific GITR-binding fusion proteins and methods of use thereof

    Inhibrx, Inc. · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  23. US 9920109

    Serpin fusion polypeptides and methods of purification thereof

    Inhibrx, Inc. · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  24. US 9914765

    WAP domain fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted